Acumen Pharmaceuticals SEC Filing Effective
Ticker: ABOS · Form: EFFECT · Filed: 2026-04-02T00:15:31-04:00
Sentiment: neutral
Topics: registration-statement, sec-filing, effectiveness
TL;DR
Acumen Pharma's registration statement is now SEC effective as of 4/1/26. Get ready.
AI Summary
Acumen Pharmaceuticals, Inc. filed an EFFECT form on April 2, 2026, indicating the effectiveness of a registration statement. The filing, with SEC Accession No. 9999999995-26-001054, pertains to Act 33 and has a file number of 333-294649. The effectiveness date is April 1, 2026.
Why It Matters
This filing signifies that Acumen Pharmaceuticals, Inc. has met the SEC's requirements for a registration statement to become effective, likely paving the way for a securities offering.
Risk Assessment
Risk Level: low — This is a routine administrative filing confirming the effectiveness of a registration statement, not indicating new financial performance or significant operational changes.
Key Numbers
- 2026-04-01 — Effectiveness Date (The date the registration statement became effective.)
- 2026-04-02 — Filing Acceptance Date (The date the SEC accepted the filing.)
Key Players & Entities
- Acumen Pharmaceuticals, Inc. (company) — Filer
- 9999999995-26-001054 (dollar_amount) — SEC Accession Number
- 2026-04-02 (dollar_amount) — Acceptance Date
- 2026-04-01 (dollar_amount) — Effectiveness Date
- 333-294649 (dollar_amount) — File Number
FAQ
What type of filing is this EFFECT form related to?
This EFFECT form is related to the effectiveness of a registration statement filed under Act 33.
What is the SEC Accession Number for this filing?
The SEC Accession Number for this filing is 9999999995-26-001054.
When did the registration statement become effective?
The registration statement became effective on April 1, 2026.
What is the File Number associated with this filing?
The File Number associated with this filing is 333-294649.
What is the primary business of Acumen Pharmaceuticals, Inc. according to the filing?
According to the filing, Acumen Pharmaceuticals, Inc. is in the business of Biological Products, (No Diagnostic Substances) (SIC Code 2836).
From the Filing
EDGAR Filing Documents for 9999999995-26-001054 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form EFFECT - Notice of Effectiveness: SEC Accession No. 9999999995-26-001054 Accepted 2026-04-02 00:15:31 Documents 1 Effectiveness Date 2026-04-01 Document Format Files Seq Description Document Type Size 1 primary_doc.html EFFECT 1 primary_doc.xml EFFECT 598 Complete submission text file 9999999995-26-001054.txt 1794 Mailing Address 1210-1220 WASHINGTON STREET SUITE 210 NEWTON MA 02465 Business Address 1210-1220 WASHINGTON STREET SUITE 210 NEWTON MA 02465 617-344-4190 Acumen Pharmaceuticals, Inc. (Filer) CIK : 0001576885 (see all company filings) EIN. : 364108129 | State of Incorp.: DE | Fiscal Year End: 1231 Type: EFFECT | Act: 33 | File No.: 333-294649 | Film No.: 26830460 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)